fluorouracil has been researched along with thonzylamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, T; Eguchi, S; Hidaka, M; Inoue, Y; Isagawa, Y; Ito, S; Kanetaka, K; Kawaguchi, Y; Kobayashi, K; Kobayashi, S; Kosaka, T; Kuba, S; Maruya, Y; Migita, K; Morita, M; Okada, S; Takatsuki, M; Torashima, Y; Yamaguchi, S; Yoneda, A; Yoshimoto, T | 1 |
1 other study(ies) available for fluorouracil and thonzylamine
| Article | Year |
|---|---|
Downstaging and Histological Effects Might Be Reliable Predictors of the Efficacy of DOC+CDDP+5-FU (DCF) as Neoadjuvant Therapy for Stage III or Borderline Resectable Esophageal Cancer: a Single Institute Experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Mucosa; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagoscopy; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pyrimidines; Retrospective Studies | 2021 |